ESC Professional Premium Access

Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: Insights from PARADIGM-HF

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Paolo Tolomeo

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
0 follower

7 more presentations in this session

Predicting the long-termoutcome of patients admitted with acute heart failure to the emergency department using renal markers

Speaker: Doctor J. Borges-Rosa (Coimbra, PT)


Prognostic value of estimating appendicular muscle mass in heart failure using creatinine/cystatin C

Speaker: Doctor T. Sunayama (Tokyo, JP)


Clinical impact of chronic kidney disease on appendicular skeletal muscle mass and mortality in hospitalized patients with acute heart failure

Speaker: Mr E. Akiyama (Saitama, JP)


Causes of death in patients with chronic kidney disease: Insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials

Speaker: Professor A. Singh (Boston, US)


Incidence of heart failure and renal endpoints in heart failure patients with and without severe chronic kidney disease: a nationwide real-life study of 21,959 patients

Speaker: Miss D. Zahir (Hellerup, DK)


Access the full session

Chronic heart failure - The kidney and heart failure

Speakers: Doctor P. Tolomeo, Doctor J. Borges-Rosa, Doctor T. Sunayama, Mr E. Akiyama, Professor A. Singh...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb